Semen Analysis Market By Product (Semen Analyzers, Centrifuges for Sample Preparation, Semen Test Kits, Disposables and Consumables, Software), By Age Group (34 and below 34 years, 35-40 years, 41 and greater than 41 years), By End User (Fertility Centers, Hospitals, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global semen analysis market was valued at $955.47 million in 2021, and is projected to reach $1,486.78 million by 2031, registering a CAGR of 4.5% from 2022 to 2031.
A semen analysis also called seminogram or spermiogram, is an important diagnostic tool for the evaluation of male fertility, by examining the male semen and the sperms present within. It is done to help evaluate male fertility, whether for those seeking pregnancy or verifying the success of vasectomy. It is a complex test that should be performed in andrology laboratories by experienced technicians with quality control and validation of test systems. A routine semen analysis should include: physical characteristics of semen (color, odor, pH, viscosity and liquefaction), volume, concentration, morphology and sperm motility and progression. It is necessary to perform at least two, preferably three, separate seminal analyses with an interval of seven days to three months between them to obtain a reliable result.
The major factors that drive the growth of the global semen analysis market include, increase in incidences of male infertility. For instance, according to a report published by the World Health Organization (WHO), one in every four couples in developing countries are affected by infertility. Poor sperm fertility & motility, lower sperm count, and abnormally shaped sperm are some of the few concerns related to infertility in males. As a result, demand for various infertility and artificial insemination techniques such as In Vitro Fertilization (IVF) and donor insemination are expected to rise, ultimately driving the market growth. Furthermore, growth in awareness regarding fertility testing in both developed and developing countries boost the growth of the market. Moreover, innovation and advancement in male fertility testing such as automation in sperm analysis with the use of flow cytometry for evaluation of cell counts and utilization of a new membrane-permeant nucleic acid stain for evaluation of sperm viability as well as standardize manual semen analysis, computer-assisted sperm analysis (CASA) systems have been developed, which further boost growth of the market.
However, lack of awareness in economically poor countries about semen analysis is likely to restrain the growth of the semen analysis market during the forecast period. Conversely, sales of male fertility testing kits on online platform and growth potential of emerging economies are some factors which is anticipated to provide lucrative opportunities for the market players.
The semen analysis market is segmented into product, age group, end user and region. According to product, the market is categorized into semen analyzers, centrifuges for sample preparation, semen test kits, disposables & consumables, and software. Semen analyzer segment is further sub-segmented into manual semen analyzer, and automated semen analyzer. By age group, it is segregated into 34 and below 34 years, 35-40 years, and 41 and greater than 41 years. On the basis of end user, it is segmented into fertility centers, hospitals, diagnostic laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Androfert, Arquimea (Arquimea Agrotech), Bioline Technologies, Cooper Companies Inc (Cooper Surgical), DNA Diagnostics Center, Inc., FlowLabs, Hamilton Thorne Inc., Lab IVF, Leja Products B.V, Medical Electronics Systems, Michigan center for fertility & women's health, Microptic SL, Midland Fertility, MotilityCount ApS, NW Cryobank, Sperm processor, and Synergy medical systems.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the semen analysis market analysis from 2021 to 2031 to identify the prevailing semen analysis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the semen analysis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global semen analysis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Semen Analyzers
Type
Manual Semen Analyzers
Automated Semen Analyzers
Centrifuges for Sample Preparation
Semen Test Kits
Disposables and Consumables
Software
By Age Group
34 and below 34 years
35-40 years
41 and greater than 41 years
By End User
Fertility Centers
Hospitals
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Androfert
Arquimea (Arquimea Agrotech)
Bioline Technologies
Cooper Companies Inc (Cooper Surgical)
DNA Diagnostics Center, Inc.
FlowLabs
Hamilton Thorne Inc.
Lab IVF
Leja Products B.V
Medical electronics systems
Michigan center for fertility & women's health
Microptic SL
Midland Fertility
MotilityCount ApS
NW Cryobank
Sperm processor
Synergy medical systems
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SEMEN ANALYSIS MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Semen Analyzers
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Semen Analyzers Semen Analysis Market by Type
- 4.3 Centrifuges for Sample Preparation
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Semen Test Kits
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Disposables and Consumables
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Software
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- CHAPTER 5: SEMEN ANALYSIS MARKET, BY AGE GROUP
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 34 and below 34 years
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 35-40 years
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 41 and greater than 41 years
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: SEMEN ANALYSIS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Fertility Centers
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Diagnostic Laboratories
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- CHAPTER 7: SEMEN ANALYSIS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Age Group
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Age Group
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Age Group
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Age Group
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Age Group
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Age Group
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Age Group
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Age Group
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Age Group
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Age Group
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Age Group
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Age Group
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Age Group
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Age Group
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Age Group
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Age Group
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Age Group
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Age Group
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Age Group
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Age Group
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Age Group
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Age Group
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Age Group
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Androfert
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Arquimea (Arquimea Agrotech)
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Bioline Technologies
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Cooper Companies Inc (Cooper Surgical)
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 DNA Diagnostics Center, Inc.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 FlowLabs
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Hamilton Thorne Inc.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Lab IVF
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Leja Products B.V
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Medical electronics systems
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Michigan center for fertility & women's health
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Microptic SL
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Midland Fertility
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 MotilityCount ApS
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 NW Cryobank
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Sperm processor
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Synergy medical systems
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. SEMEN ANALYSIS MARKET SIZE, FOR SEMEN ANALYZERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. SEMEN ANALYSIS MARKET FOR SEMEN ANALYZERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL SEMEN ANALYZERS SEMEN ANALYSIS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 5. SEMEN ANALYSIS MARKET SIZE, FOR CENTRIFUGES FOR SAMPLE PREPARATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. SEMEN ANALYSIS MARKET FOR CENTRIFUGES FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 7. SEMEN ANALYSIS MARKET SIZE, FOR SEMEN TEST KITS, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. SEMEN ANALYSIS MARKET FOR SEMEN TEST KITS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. SEMEN ANALYSIS MARKET SIZE, FOR DISPOSABLES AND CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. SEMEN ANALYSIS MARKET FOR DISPOSABLES AND CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. SEMEN ANALYSIS MARKET SIZE, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. SEMEN ANALYSIS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. GLOBAL SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 14. SEMEN ANALYSIS MARKET SIZE, FOR 34 AND BELOW 34 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. SEMEN ANALYSIS MARKET FOR 34 AND BELOW 34 YEARS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. SEMEN ANALYSIS MARKET SIZE, FOR 35-40 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. SEMEN ANALYSIS MARKET FOR 35-40 YEARS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. SEMEN ANALYSIS MARKET SIZE, FOR 41 AND GREATER THAN 41 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. SEMEN ANALYSIS MARKET FOR 41 AND GREATER THAN 41 YEARS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. GLOBAL SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 21. SEMEN ANALYSIS MARKET SIZE, FOR FERTILITY CENTERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. SEMEN ANALYSIS MARKET FOR FERTILITY CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. SEMEN ANALYSIS MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. SEMEN ANALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. SEMEN ANALYSIS MARKET SIZE, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. SEMEN ANALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 27. SEMEN ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 28. SEMEN ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. SEMEN ANALYSIS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 30. NORTH AMERICA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 31. NORTH AMERICA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA SEMEN ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 34. U.S. SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 35. U.S. SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 36. U.S. SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 37. CANADA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 38. CANADA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 39. CANADA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 40. MEXICO SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 41. MEXICO SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 42. MEXICO SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 43. EUROPE SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 44. EUROPE SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 45. EUROPE SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 46. EUROPE SEMEN ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 47. GERMANY SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 48. GERMANY SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 49. GERMANY SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 50. FRANCE SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 51. FRANCE SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 52. FRANCE SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 53. UK SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 54. UK SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 55. UK SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 56. ITALY SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 57. ITALY SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 58. ITALY SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 59. SPAIN SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 60. SPAIN SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 61. SPAIN SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 62. REST OF EUROPE SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 63. REST OF EUROPE SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 64. REST OF EUROPE SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 65. ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 66. ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 67. ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 68. ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 69. JAPAN SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 70. JAPAN SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 71. JAPAN SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. CHINA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 73. CHINA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 74. CHINA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 75. INDIA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 76. INDIA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 77. INDIA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 78. AUSTRALIA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 79. AUSTRALIA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 80. AUSTRALIA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. SOUTH KOREA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 82. SOUTH KOREA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 83. SOUTH KOREA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. REST OF ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 85. REST OF ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 86. REST OF ASIA-PACIFIC SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 87. LAMEA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 88. LAMEA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 89. LAMEA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 90. LAMEA SEMEN ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 91. BRAZIL SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 92. BRAZIL SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 93. BRAZIL SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 94. SAUDI ARABIA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 95. SAUDI ARABIA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 96. SAUDI ARABIA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97. SOUTH AFRICA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 98. SOUTH AFRICA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 99. SOUTH AFRICA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 100. REST OF LAMEA SEMEN ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 101. REST OF LAMEA SEMEN ANALYSIS MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 102. REST OF LAMEA SEMEN ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 103.ANDROFERT: COMPANY SNAPSHOT
- TABLE 104.ANDROFERT: OPERATING SEGMENTS
- TABLE 105.ANDROFERT: PRODUCT PORTFOLIO
- TABLE 106.ANDROFERT: NET SALES,
- TABLE 107.ANDROFERT: KEY STRATERGIES
- TABLE 108.ARQUIMEA (ARQUIMEA AGROTECH): COMPANY SNAPSHOT
- TABLE 109.ARQUIMEA (ARQUIMEA AGROTECH): OPERATING SEGMENTS
- TABLE 110.ARQUIMEA (ARQUIMEA AGROTECH): PRODUCT PORTFOLIO
- TABLE 111.ARQUIMEA (ARQUIMEA AGROTECH): NET SALES,
- TABLE 112.ARQUIMEA (ARQUIMEA AGROTECH): KEY STRATERGIES
- TABLE 113.BIOLINE TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 114.BIOLINE TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 115.BIOLINE TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 116.BIOLINE TECHNOLOGIES: NET SALES,
- TABLE 117.BIOLINE TECHNOLOGIES: KEY STRATERGIES
- TABLE 118.COOPER COMPANIES INC (COOPER SURGICAL): COMPANY SNAPSHOT
- TABLE 119.COOPER COMPANIES INC (COOPER SURGICAL): OPERATING SEGMENTS
- TABLE 120.COOPER COMPANIES INC (COOPER SURGICAL): PRODUCT PORTFOLIO
- TABLE 121.COOPER COMPANIES INC (COOPER SURGICAL): NET SALES,
- TABLE 122.COOPER COMPANIES INC (COOPER SURGICAL): KEY STRATERGIES
- TABLE 123.DNA DIAGNOSTICS CENTER, INC.: COMPANY SNAPSHOT
- TABLE 124.DNA DIAGNOSTICS CENTER, INC.: OPERATING SEGMENTS
- TABLE 125.DNA DIAGNOSTICS CENTER, INC.: PRODUCT PORTFOLIO
- TABLE 126.DNA DIAGNOSTICS CENTER, INC.: NET SALES,
- TABLE 127.DNA DIAGNOSTICS CENTER, INC.: KEY STRATERGIES
- TABLE 128.FLOWLABS: COMPANY SNAPSHOT
- TABLE 129.FLOWLABS: OPERATING SEGMENTS
- TABLE 130.FLOWLABS: PRODUCT PORTFOLIO
- TABLE 131.FLOWLABS: NET SALES,
- TABLE 132.FLOWLABS: KEY STRATERGIES
- TABLE 133.HAMILTON THORNE INC.: COMPANY SNAPSHOT
- TABLE 134.HAMILTON THORNE INC.: OPERATING SEGMENTS
- TABLE 135.HAMILTON THORNE INC.: PRODUCT PORTFOLIO
- TABLE 136.HAMILTON THORNE INC.: NET SALES,
- TABLE 137.HAMILTON THORNE INC.: KEY STRATERGIES
- TABLE 138.LAB IVF: COMPANY SNAPSHOT
- TABLE 139.LAB IVF: OPERATING SEGMENTS
- TABLE 140.LAB IVF: PRODUCT PORTFOLIO
- TABLE 141.LAB IVF: NET SALES,
- TABLE 142.LAB IVF: KEY STRATERGIES
- TABLE 143.LEJA PRODUCTS B.V: COMPANY SNAPSHOT
- TABLE 144.LEJA PRODUCTS B.V: OPERATING SEGMENTS
- TABLE 145.LEJA PRODUCTS B.V: PRODUCT PORTFOLIO
- TABLE 146.LEJA PRODUCTS B.V: NET SALES,
- TABLE 147.LEJA PRODUCTS B.V: KEY STRATERGIES
- TABLE 148.MEDICAL ELECTRONICS SYSTEMS: COMPANY SNAPSHOT
- TABLE 149.MEDICAL ELECTRONICS SYSTEMS: OPERATING SEGMENTS
- TABLE 150.MEDICAL ELECTRONICS SYSTEMS: PRODUCT PORTFOLIO
- TABLE 151.MEDICAL ELECTRONICS SYSTEMS: NET SALES,
- TABLE 152.MEDICAL ELECTRONICS SYSTEMS: KEY STRATERGIES
- TABLE 153.MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH: COMPANY SNAPSHOT
- TABLE 154.MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH: OPERATING SEGMENTS
- TABLE 155.MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH: PRODUCT PORTFOLIO
- TABLE 156.MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH: NET SALES,
- TABLE 157.MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH: KEY STRATERGIES
- TABLE 158.MICROPTIC SL: COMPANY SNAPSHOT
- TABLE 159.MICROPTIC SL: OPERATING SEGMENTS
- TABLE 160.MICROPTIC SL: PRODUCT PORTFOLIO
- TABLE 161.MICROPTIC SL: NET SALES,
- TABLE 162.MICROPTIC SL: KEY STRATERGIES
- TABLE 163.MIDLAND FERTILITY: COMPANY SNAPSHOT
- TABLE 164.MIDLAND FERTILITY: OPERATING SEGMENTS
- TABLE 165.MIDLAND FERTILITY: PRODUCT PORTFOLIO
- TABLE 166.MIDLAND FERTILITY: NET SALES,
- TABLE 167.MIDLAND FERTILITY: KEY STRATERGIES
- TABLE 168.MOTILITYCOUNT APS: COMPANY SNAPSHOT
- TABLE 169.MOTILITYCOUNT APS: OPERATING SEGMENTS
- TABLE 170.MOTILITYCOUNT APS: PRODUCT PORTFOLIO
- TABLE 171.MOTILITYCOUNT APS: NET SALES,
- TABLE 172.MOTILITYCOUNT APS: KEY STRATERGIES
- TABLE 173.NW CRYOBANK: COMPANY SNAPSHOT
- TABLE 174.NW CRYOBANK: OPERATING SEGMENTS
- TABLE 175.NW CRYOBANK: PRODUCT PORTFOLIO
- TABLE 176.NW CRYOBANK: NET SALES,
- TABLE 177.NW CRYOBANK: KEY STRATERGIES
- TABLE 178.SPERM PROCESSOR: COMPANY SNAPSHOT
- TABLE 179.SPERM PROCESSOR: OPERATING SEGMENTS
- TABLE 180.SPERM PROCESSOR: PRODUCT PORTFOLIO
- TABLE 181.SPERM PROCESSOR: NET SALES,
- TABLE 182.SPERM PROCESSOR: KEY STRATERGIES
- TABLE 183.SYNERGY MEDICAL SYSTEMS: COMPANY SNAPSHOT
- TABLE 184.SYNERGY MEDICAL SYSTEMS: OPERATING SEGMENTS
- TABLE 185.SYNERGY MEDICAL SYSTEMS: PRODUCT PORTFOLIO
- TABLE 186.SYNERGY MEDICAL SYSTEMS: NET SALES,
- TABLE 187.SYNERGY MEDICAL SYSTEMS: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SEMEN ANALYSIS MARKET SEGMENTATION
- FIGURE 2.SEMEN ANALYSIS MARKET,2021-2031
- FIGURE 3.SEMEN ANALYSIS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SEMEN ANALYSIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.SEMEN ANALYSIS MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SEMEN ANALYZERS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CENTRIFUGES FOR SAMPLE PREPARATION SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SEMEN TEST KITS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DISPOSABLES AND CONSUMABLES SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SOFTWARE SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 18.SEMEN ANALYSIS MARKET,BY AGE GROUP,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF 34 AND BELOW 34 YEARS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF 35-40 YEARS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF 41 AND GREATER THAN 41 YEARS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 22.SEMEN ANALYSIS MARKET,BY END USER,2021(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF FERTILITY CENTERS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF OTHERS SEMEN ANALYSIS MARKET,2021-2031(%)
- FIGURE 27.SEMEN ANALYSIS MARKET BY REGION,2021
- FIGURE 28.U.S. SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 29.CANADA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 30.MEXICO SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 31.GERMANY SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 32.FRANCE SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 33.UK SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 34.ITALY SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 35.SPAIN SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 36.REST OF EUROPE SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 37.JAPAN SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 38.CHINA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 39.INDIA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 40.AUSTRALIA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 41.SOUTH KOREA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 42.REST OF ASIA-PACIFIC SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 43.BRAZIL SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 44.SAUDI ARABIA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 45.SOUTH AFRICA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 46.REST OF LAMEA SEMEN ANALYSIS MARKET,2021-2031($MILLION)
- FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 51.COMPETITIVE DASHBOARD
- FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 53.ANDROFERT.: NET SALES ,($MILLION)
- FIGURE 54.ARQUIMEA (ARQUIMEA AGROTECH).: NET SALES ,($MILLION)
- FIGURE 55.BIOLINE TECHNOLOGIES.: NET SALES ,($MILLION)
- FIGURE 56.COOPER COMPANIES INC (COOPER SURGICAL).: NET SALES ,($MILLION)
- FIGURE 57.DNA DIAGNOSTICS CENTER, INC..: NET SALES ,($MILLION)
- FIGURE 58.FLOWLABS.: NET SALES ,($MILLION)
- FIGURE 59.HAMILTON THORNE INC..: NET SALES ,($MILLION)
- FIGURE 60.LAB IVF.: NET SALES ,($MILLION)
- FIGURE 61.LEJA PRODUCTS B.V.: NET SALES ,($MILLION)
- FIGURE 62.MEDICAL ELECTRONICS SYSTEMS.: NET SALES ,($MILLION)
- FIGURE 63.MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH.: NET SALES ,($MILLION)
- FIGURE 64.MICROPTIC SL.: NET SALES ,($MILLION)
- FIGURE 65.MIDLAND FERTILITY.: NET SALES ,($MILLION)
- FIGURE 66.MOTILITYCOUNT APS.: NET SALES ,($MILLION)
- FIGURE 67.NW CRYOBANK.: NET SALES ,($MILLION)
- FIGURE 68.SPERM PROCESSOR.: NET SALES ,($MILLION)
- FIGURE 69.SYNERGY MEDICAL SYSTEMS.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook